Investors

03

Invest in the Future of Point-of-Care Diagnostics.

Invest in the Future of Point-of-Care Diagnostics.

A rapid, quantitative HbA1c platform built on proprietary electrochemical engineering and scalable consumables.

A rapid, quantitative HbA1c platform built on proprietary electrochemical engineering and scalable consumables.

Platform First

Platform First

Engineered as a modular point-of-care system built for scale, longevity, and multi-analyte expansion.

Engineered as a modular point-of-care system built for scale, longevity, and multi-analyte expansion.

Near-instant output

Designed for swift, in-clinic HbA1c measurement workflows. Without reliance on external labs.

Scalable test menu

A future-facing technology stack enabling multi-analyte expansion.

A future-facing technology stack enabling multi-analyte expansion.

120M+

120M+

Annual HbA1c Tests (U.S)

Annual HbA1c Tests (U.S)

80%+

80%+

US Clinics depend on external lab processing

US Clinics depend on external lab processing

2 days

2 days

Average lab turnaround time

Average lab turnaround time

Business Model: Razor & Blade

Our platform combines durable, professional-grade hardware with scalable, single-use test strips. This dual architecture supports both device placement and recurring consumables revenue.

Test strips are engineered for consistent usage cycles and predictable margins, enabling reliable revenue generation. The hardware platform is designed for longevity, automated manufacturing compatibility, and multi-analyte expansion.

This model aligns financial incentives for adoption, elevates device lifetime value, and supports a broader roadmap of analytes and future product integrations.

Engineering Development

2025

Bench Testing

Q4 2025

Professional-Use Alignment

Q2 2026

Pilot Rollout

Q4 2026

Regulatory Submission Package

Q1 2027

Join the Next Round.

Join the Next Round.

Request investor materials or connect with the founding team.

Request investor materials or connect with the founding team.

Request investor materials or connect with the founding team.

Request Investor Materials